Lupin Invests $250 Million in New Coral Springs Manufacturing Facility
Pharmaceutical company Lupin is constructing a state-of-the-art manufacturing facility in Coral Springs, FL, to produce critical respiratory medicines.
The $250 million investment will create over 200 jobs and reinforce domestic manufacturing and drug security, producing more than 25 critical respiratory medicines, including albuterol inhalers.
- Manufacturing capacity: over 25 critical respiratory medicines
- Job creation: over 200 new long-term, skilled jobs by 2030
- Investment: approximately $250 million over five years
The new plant offers various positives, including a boost in local manufacturing, supply chain diversification, and the strengthening of drug security.
Author's summary: Lupin invests $250 million in a new manufacturing facility.